MedPath
FDA Approval

Naproxen

FDA-approved pharmaceutical product with comprehensive regulatory information, manufacturing details, and complete labeling documentation.

FDA Approval Summary

Company
Effective Date
January 1, 2024
Labeling Type
HUMAN PRESCRIPTION DRUG LABEL
Naproxen(375 mg in 1 1)

Registrants1

Companies and organizations registered with the FDA for this drug approval, including their contact information and regulatory details.

Northwind Pharmaceuticals, LLC

036986393

Manufacturing Establishments1

FDA-registered manufacturing facilities and establishments involved in the production, packaging, or distribution of this drug product.

Northwind Pharmaceuticals, LLC

Northwind Pharmaceuticals, LLC

Northwind Pharmaceuticals, LLC

036986393

Products1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Naproxen

Product Details

NDC Product Code
82868-030
Application Number
ANDA074140
Marketing Category
ANDA (C73584)
Route of Administration
ORAL
Effective Date
January 1, 2024
POVIDONE K90Inactive
Code: RDH86HJV5ZClass: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48Class: IACT
WATERInactive
Code: 059QF0KO0RClass: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30Class: IACT
NaproxenActive
Code: 9TN87S3A3CClass: ACTIBQuantity: 375 mg in 1 1
© Copyright 2025. All Rights Reserved by MedPath